Showing results (3051-3060 of 10,589) with videos related to
Sort By:
Pageof 1,059
Thrombosis Research|April 1, 2017
Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndromeTeresa Iwaniec, Marcin P Kaczor, Magdalena Celińska-Löwenhoff, et al.Thrombosis Research|May 1, 1988
Characterization of a new compound, S-145, as a specific TXA2 receptor antagonist in plateletsK Hanasaki, H AritaThrombosis Research|April 14, 2017
Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancerH E Fuentes, D M Oramas, L H Paz, et al.Thrombosis Research|April 1, 1988
The alkenylacyl class of ethanolamine phospholipid represents a major form of eicosapentaenoic acid (EPA)-containing phospholipid in the platelets of human subjects consuming a fish oil concentrateB J Holub, B Celi, C M SkeaffThrombosis Research|November 6, 2021
Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trialAmeeta L Nayak, Amin Zahrai, Ranjeeta Mallick, et al.Thrombosis Research|November 7, 2021
Validation of risk assessment models for venous thromboembolism and bleeding in critically ill adolescentsAnjali Gupta, Madhuradhar Chegondi, Ramya Deepthi Billa, et al.Thrombosis Research|April 1, 1986
Rat platelet aggregation: strain and stock variationsS D Dwyer, K M MeyersThrombosis Research|March 5, 2021
Influence of PAR-1 in patients with non-valvular atrial fibrillation: The antiplatelet effect of dabigatranKiyotaka Oi, Mie Shimizu, Tatsunori Natori, et al.Thrombosis Research|July 15, 1987
Effect of latamoxef (moxalactam) and its related compounds on platelet aggregation in vitro--structure activity relationshipsK Uchida, H Kakushi, T ShikeThrombosis Research|September 3, 2019
Trends of cancer-associated venous thromboembolism (VTE) in the United States (2005-2014)Omar A Almohammed, Leanne Lai, Nile M Khanfar, et al.Pageof 1,059